ARYA Sciences Acquisition Corp.

Status: Deal Closed
U=S+W/2 W=S@11.5
IPO Proceeds, $M $143.75M
IPO Date Oct 5, 2018
CEO Adam Stone
Left Lead Jefferies
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare
IPO Geography Global
Target Company Immatics Biotech
Deal Announced Mar 17, 2020
Deal Size, $M $314.85M
Deal Sector Healthcare
Deal Geography Europe
SEC Filings www.sec.gov
Approval Vote Jun 29, 2020
Amendment Vote TBD
Closing Date Jul 1, 2020
Formerly ARYA IMTX IMTXW

Sign up for Free Trial

No credit card required

Sign in for more on ARYA Sciences Acquisition Corp.:

  • Structure and cap table
  • 6 directors & officers
  • 25 filings and events
  • 2 underwriters
  • 8 deal advisors
  • 3 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Joseph Edelman 63 Chairman
Adam Stone 39 CEO & Director
Michael Altman 36 CFO & Director
Kevin Conroy 53 Director
Dr. Todd Wider 53 Director
Dr. David Hung 61 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Jefferies BR 10,000,000 units
Chardan 2,500,000
12,500,000 units
Up-Front UW fee 2.75 %
Deferred UW fee 3.25 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 25 filings.

Shareholders

Sign in to view shareholders 13F filing data.